Oral Anticoagulants and Aspirin Use and Its Effect on Positive  Predictive Value of Fecal Immunochemical Test for Advanced Neoplasia in Colorectal Cancer Screening: To Bleed or Not to Bleed

Colorectal cancer (CRC) has a significant impact on public health owing to its high incidence, morbidity, and mortality.1 It is the third most common cancer in men and second in women, and in most countries the second leading cause of cancer-related death.1,2 The early detection and removal of precursor cancer lesions decreases CRC incidence and mortality. CRC screening has, therefore, been implemented in various countries worldwide.3 The selected modality varies per country or region and differs from primary colonoscopy, sigmoidoscopy to noninvasive testing, in particular by means of a fecal immunochemical test (FIT).
Source: Gastroenterology - Category: Gastroenterology Authors: Tags: Editorial Source Type: research